Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation Research
Search: search_blue_button Advanced Search
Circulation Research. 2009
Published online before print September 24, 2009, doi: 10.1161/CIRCRESAHA.109.199471
A more recent version of this article appeared on November 6, 2009
This Article
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow All Versions of this Article:
105/10/973    most recent
CIRCRESAHA.109.199471v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Bujak, M.
Right arrow Articles by Frangogiannis, N. G.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bujak, M.
Right arrow Articles by Frangogiannis, N. G.
Related Collections
Right arrow Remodeling
Right arrow Animal models of human disease
Right arrow Growth factors/cytokines
Right arrow Ischemic biology - basic studies
Right arrow Acute myocardial infarction

Submitted on April 20, 2009
Revised on September 15, 2009
Accepted on September 15, 2009

Induction of the CXC Chemokine Interferon-{gamma}–Inducible Protein 10 Regulates the Reparative Response Following Myocardial Infarction

Marcin Bujak ; Marcin Dobaczewski ; Carlos Gonzalez-Quesada ; Ying Xia ; Thorsten Leucker ; Pawel Zymek ; Vikas Veeranna ; Andrew M. Tager ; Andrew D. Luster ; and Nikolaos G. Frangogiannis *

From the Section of Cardiovascular Sciences (M.B., M.D., C.G.-Q., Y.X., T.L., P.Z., V.V., and N.G.F), Department of Medicine, Baylor College of Medicine, Houston, Tex; and Center for Immunology and Inflammatory Diseases (A.M.T. and A.D.L), Massachusetts General Hospital and Harvard Medical School, Charlestown.

* To whom correspondence should be addressed. E-mail: ngf{at}bcm.tmc.edu.

Rationale: Interferon-{gamma}–inducible protein (IP)-10/CXCL10, an angiostatic and antifibrotic chemokine with an important role in T-cell trafficking, is markedly induced in myocardial infarcts, and may regulate the reparative response.

Objective: To study the role of IP-10 in cardiac repair and remodeling.

Methods and Results: We studied cardiac repair in IP-10–null and wild-type (WT) mice undergoing reperfused infarction protocols and examined the effects of IP-10 on cardiac fibroblast function. IP-10–deficient and WT animals had comparable acute infarct size. However, the absence of IP-10 resulted in a hypercellular early reparative response and delayed contraction of the scar. Infarcted IP-10-/- hearts exhibited accentuated early dilation, followed by rapid wall thinning during infarct maturation associated with systolic dysfunction. Although IP-10–null and WT mice had comparable cytokine expression, the absence of IP-10 was associated with marked alterations in the cellular content of the infarct. IP-10-/- infarcts had more intense infiltration with CD45+ leukocytes, Mac-2+ macrophages, and {alpha}-smooth muscle actin ({alpha}-SMA)+ myofibroblasts than WT infarcts but exhibited reduced recruitment of the subpopulations of leukocytes, T lymphocytes and {alpha}-SMA+ cells that expressed CXCR3, the IP-10 receptor. IP-10 did not modulate cardiac fibroblast proliferation and apoptosis but significantly inhibited basic fibroblast growth factor–induced fibroblast migration. In addition, IP-10 enhanced growth factor–mediated wound contraction in fibroblast-populated collagen lattices.

Conclusions: Endogenous IP-10 is an essential inhibitory signal that regulates the cellular composition of the healing infarct and promotes wound contraction, attenuating adverse remodeling. IP-10–mediated actions may be due, at least in part, to direct effects on fibroblast migration and function.


Key words: infarction • remodeling • chemokines • fibrosis • wound healing